Cargando…
Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats
Traumatic brain injury is a leading cause of death and disability around the world. So far, drugs are not available to repair brain damage. Human mesenchymal stem cell (hMSC) transplantation therapy is a promising approach, although the inflammatory microenvironment of the injured brain affects the...
Autores principales: | Das, Mahasweta, Mayilsamy, Karthick, Tang, Xiaolan, Han, Jung Yeon, Foran, Elspeth, Willing, Alison E., Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754424/ https://www.ncbi.nlm.nih.gov/pubmed/31541141 http://dx.doi.org/10.1038/s41598-019-49428-y |
Ejemplares similares
-
CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies
por: Das, Mahasweta, et al.
Publicado: (2019) -
Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury
por: Willing, Alison E., et al.
Publicado: (2020) -
Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity
por: Das, Mahasweta, et al.
Publicado: (2017) -
New perspectives on central and peripheral immune responses to acute traumatic brain injury
por: Das, Mahasweta, et al.
Publicado: (2012) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)